Headerlogotextwithshieldsshadowed

2021 Course Schedule
Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology

Virtual Meeting

Tentative schedule — times subject to change

Monday, November 1, 2021

10:00 A.M.
Opening Remarks Rakesh K. Jain
10:10 A.M.
Tumor Microenvironment I: Angiogenesis and Vascular Function Rakesh K. Jain
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Tumor Microenvironment II: Vascular Normalization and Immunotherapy  Rakesh K. Jain
1:05 P.M.
Q&A
1:20 P.M.
Break
2:00 P.M.
Tumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis Rakesh K. Jain
3:05 P.M.
Q&A
3:20 P.M.
Break
4:00 P.M.
Cancer Immunology: An Introduction Arlene Sharpe
5:05 P.M.
Q&A
5:20 P.M.
Adjourn

Tuesday, November 2, 2021

10:00 A.M.
Fibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer David Tuveson
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Antiangiogenesis and Immune Checkpoint Combinations for the Treatment of Cancer F. Stephen Hodi
1:05 P.M.
Q&A
1:20 P.M.
Break
2:00 P.M.
A Systems Approach to Human Immunology and Tumor Immunity Nir Hacohen
3:05 P.M.
Q&A
3:20 P.M.
Break
4:00 P.M.
Inflammation and Cancer: Response and Resistance Programs Regulated by Leukocytes Lisa M. Coussens
5:05 P.M.
Q&A
5:20 P.M.
Adjourn

Wednesday, November 3, 2021

10:00 A.M.
Determinants of How Tumors Use Metabolism to Support Growth Matthew Vander Heiden
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Role of Microbiome in Cancer Treatment Jennifer Wargo
1:05 P.M.
Q&A
1:20 P.M.
Break
2:00 P.M.
Heterogeneity Through Space and Time Drives the Clinical Behavior of Childhood Brain Tumors Michael D. Taylor
3:05 P.M.
Q&A
3:20 P.M.
Break
4:00 P.M.
Dissecting the Tumor Microenvironment using Single-Cell Sequencing Mario Suva
5:05 P.M.
Q&A
5:20 P.M.
Adjourn

Thursday, November 4, 2021

10:00 A.M.
CAR-T Cell Therapy Carl June
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Mechanisms of Malignant Progression Robert A. Weinberg
1:05 P.M.
Q&A
1:20 P.M.
Break
2:00 P.M.
Lessons from Clinical Trials of Targeted Therapies for Cancer George W. Sledge, Jr
3:05 P.M.
Q&A
3:20 P.M.
Break
4:00 P.M.
Circadian clock and Tumor Metabolic Vulnerabilities Chi Van Dang
5:05 P.M.
Q&A
5:20 P.M.
Summary and closing remarks Rakesh K. Jain